Wall Street brokerages expect that Ducommun Incorporated (NYSE:DCO) will announce sales of $141.37 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Ducommun’s earnings, with estimates ranging from $140.74 million to $142.00 million. Ducommun reported sales of $132.57 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 6.6%. The business is expected to announce its next earnings results before the market opens on Thursday, November 2nd.

On average, analysts expect that Ducommun will report full-year sales of $141.37 million for the current financial year, with estimates ranging from $563.24 million to $563.31 million. For the next financial year, analysts forecast that the company will report sales of $582.98 million per share, with estimates ranging from $574.95 million to $591.00 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Ducommun.

Ducommun (NYSE:DCO) last issued its earnings results on Thursday, August 3rd. The aerospace company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.03. Ducommun had a net margin of 2.50% and a return on equity of 7.49%. The company had revenue of $140.90 million for the quarter, compared to the consensus estimate of $138.39 million. During the same period in the previous year, the firm earned $0.34 earnings per share. Ducommun’s quarterly revenue was up 5.6% compared to the same quarter last year.

Several research firms recently commented on DCO. B. Riley set a $40.00 price target on shares of Ducommun and gave the company a “buy” rating in a report on Monday. Canaccord Genuity raised their price target on shares of Ducommun from $35.00 to $36.00 and gave the company a “buy” rating in a report on Friday, August 4th. Sidoti lowered shares of Ducommun from a “buy” rating to a “neutral” rating in a report on Tuesday, October 17th. Zacks Investment Research lowered shares of Ducommun from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 8th. Finally, ValuEngine lowered shares of Ducommun from a “buy” rating to a “hold” rating in a report on Monday, October 2nd. Two research analysts have rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $36.25.

TRADEMARK VIOLATION NOTICE: This piece was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/10/30/141-37-million-in-sales-expected-for-ducommun-incorporated-dco-this-quarter.html.

In other news, Director Anthony J. Reardon sold 11,908 shares of the firm’s stock in a transaction that occurred on Thursday, September 21st. The shares were sold at an average price of $30.11, for a total transaction of $358,549.88. Following the completion of the sale, the director now owns 103,546 shares of the company’s stock, valued at $3,117,770.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Anthony J. Reardon sold 7,726 shares of the firm’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $27.66, for a total transaction of $213,701.16. Following the sale, the director now directly owns 123,523 shares of the company’s stock, valued at approximately $3,416,646.18. The disclosure for this sale can be found here. Insiders have sold 42,701 shares of company stock valued at $1,237,582 in the last three months. Corporate insiders own 8.20% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC grew its position in shares of Ducommun by 169.8% during the second quarter. Tower Research Capital LLC TRC now owns 3,400 shares of the aerospace company’s stock worth $107,000 after buying an additional 2,140 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in Ducommun by 15.5% in the first quarter. Envestnet Asset Management Inc. now owns 3,627 shares of the aerospace company’s stock worth $104,000 after purchasing an additional 488 shares during the period. American International Group Inc. boosted its holdings in Ducommun by 7.1% in the first quarter. American International Group Inc. now owns 6,398 shares of the aerospace company’s stock worth $184,000 after purchasing an additional 422 shares during the period. Alliancebernstein L.P. acquired a new position in Ducommun in the second quarter worth $221,000. Finally, First Trust Advisors LP acquired a new position in Ducommun in the third quarter worth $261,000. 79.84% of the stock is owned by institutional investors and hedge funds.

Ducommun (NYSE DCO) opened at 34.02 on Monday. Ducommun has a 52 week low of $18.70 and a 52 week high of $35.58. The stock has a market capitalization of $385.07 million, a P/E ratio of 28.30 and a beta of 0.86. The firm’s 50-day moving average is $32.35 and its 200-day moving average is $31.02.

Ducommun Company Profile

Ducommun Incorporated is a global provider of engineering and manufacturing services for various products and failure applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. The Company is a solution-based provider, offering a range of value-added products and services in its primary businesses of electronics, structures and integrated solutions.

Get a free copy of the Zacks research report on Ducommun (DCO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ducommun (NYSE:DCO)

Receive News & Ratings for Ducommun Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ducommun Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.